Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor + Methotrexate + Rituximab in R/R CNS Lymphoma
NCT05698147Phase 2Recruiting
- Start
- Aug 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in central nervous system lymphoma. Started Aug 2023; status: recruiting.
02
Drugs
selinexor
03
Conditions
central nervous system lymphoma
Beyond the preview
Go deeper on NCT05698147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05698147.